Get the Stockscreener App
226.64
0.21%
0.62
Iqvia Holdings Inc stock is traded at $226.64, with a volume of 55,353.
It is up +0.21% in the last 24 hours and down -2.29% over the past month.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
See More
Previous Close:
$226.02
Open:
$226.15
24h Volume:
55,353
Relative Volume:
0.04
Market Cap:
$38.60B
Revenue:
$15.90B
Net Income/Loss:
$1.28B
P/E Ratio:
31.11
EPS:
7.2842
Net Cash Flow:
$2.21B
1W Performance:
+2.63%
1M Performance:
-2.29%
6M Performance:
+43.20%
1Y Performance:
+13.10%
1-Day Range:
$225.82
$227.00
1-Week Range:
$220.08
$227.00
52-Week Range:
$134.65
$234.29
Iqvia Holdings Inc Stock (IQV) Company Profile
Name
Iqvia Holdings Inc
Sector
Industry
Phone
919-998-2000
Address
2400 ELLIS ROAD, DURHAM, NC
Compare IQV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
226.64 | 38.49B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
TMO
Thermo Fisher Scientific Inc
|
579.95 | 217.58B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
230.70 | 163.50B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
686.85 | 54.95B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
138.35 | 39.21B | 6.95B | 1.30B | 1.15B | 4.5696 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-03-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-29-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-09-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-09-25 | Upgrade | Jefferies | Hold → Buy |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-03-25 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-04-24 | Initiated | RBC Capital Mkts | Outperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jun-06-24 | Initiated | Goldman | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-15-24 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-13-24 | Initiated | BTIG Research | Buy |
| Nov-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Mar-17-23 | Initiated | Truist | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Nov-17-22 | Downgrade | Citigroup | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-29-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-16-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-08-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jul-07-20 | Initiated | Stephens | Equal-Weight |
| Mar-02-20 | Initiated | Deutsche Bank | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Dec-13-19 | Upgrade | CFRA | Sell → Hold |
| Nov-14-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-21-19 | Upgrade | Mizuho | Neutral → Buy |
| May-28-19 | Initiated | SVB Leerink | Outperform |
| Jan-18-19 | Upgrade | Jefferies | Hold → Buy |
| Oct-09-18 | Initiated | UBS | Buy |
| Oct-02-18 | Reiterated | Robert W. Baird | Outperform |
| Jul-25-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-25-18 | Reiterated | Stifel | Buy |
| Jul-03-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-13-18 | Upgrade | Goldman | Neutral → Buy |
| Mar-07-18 | Upgrade | SunTrust | Hold → Buy |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
View All
Iqvia Holdings Inc Stock (IQV) Latest News
Pacer Advisors Inc. Sells 299,354 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings (NYSE:IQV) Has A Pretty Healthy Balance Sheet - 富途牛牛
Vontobel Holding Ltd. Raises Stock Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
What dividend safety score for IQVIA Holdings Inc. stockDividend Stability Analysis & Consistent Triple Returns - Bollywood Helpline
Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 27% Discount? - Yahoo Finance
Goelzer Investment Management Inc. Cuts Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA’s Debt Refinancing Could Be A Game Changer For IQVIA Holdings (IQV) - simplywall.st
IQVIA Holdings Inc. $IQV Shares Purchased by Voya Investment Management LLC - MarketBeat
Understanding Momentum Shifts in (IQV) - Stock Traders Daily
Osaic Holdings Inc. Grows Position in IQVIA Holdings Inc. $IQV - MarketBeat
How strong is IQVIA Holdings Inc. stock earnings growthTrade Exit Report & Safe Swing Trade Setups - ulpravda.ru
IQVIA (NYSE:IQV) Raised to "Buy" at Wall Street Zen - MarketBeat
Why IQVIA Holdings Inc. stock remains on buy listsQuarterly Earnings Report & High Conviction Buy Zone Picks - DonanımHaber
Support Test: What dividend safety score for IQVIA Holdings Inc. stockQuarterly Trade Summary & Real-Time Buy Zone Alerts - ulpravda.ru
Why IQVIA Holdings Inc. (QTS) stock is a strong analyst pickJuly 2025 Weekly Recap & Stepwise Trade Execution Plans - DonanımHaber
Deutsche Bank Adjusts Price Target on IQVIA Holdings to $250 From $235, Maintains Buy Rating - marketscreener.com
Published on: 2025-12-19 16:34:29 - DonanımHaber
Why IQVIA Holdings Inc. stock is trending among retail tradersBond Market & Community Consensus Stock Picks - Улправда
Addenda Capital Inc. Raises Stock Position in IQVIA Holdings Inc. $IQV - MarketBeat
Gainers Report: What dividend safety score for IQVIA Holdings Inc. stockWeekly Profit Recap & Capital Efficient Trade Techniques - ulpravda.ru
Assenagon Asset Management S.A. Acquires 30,798 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Unveils New Custom AI Agents with NVIDIA - MSN
Stifel raises IQVIA Holdings stock price target to $273 on recovery outlook - Investing.com Canada
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MSN
Real World Evidence (RWE) Oncology Market 2025 to 2034 Research Report - Insightace Analytic
IQVIA Holdings Inc. (NYSE:IQV) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
IQVIA Holdings (FRA:QTS) Days Payable : 117.26 (As of Sep. 2025) - GuruFocus
IQVIA Holdings (FRA:QTS) Current Ratio : 0.70 (As of Sep. 2025) - GuruFocus
IQVIA Holdings (FRA:QTS) Operating Margin % : 13.98% (As of Sep. 2025) - GuruFocus
IQVIA Holdings (FRA:QTS) Shares Outstanding (EOP) : 170 Mil (As of Sep. 2025) - GuruFocus
IQVIA Holdings (FRA:QTS) Price-to-Owner-Earnings : 19.68 (As of Dec. 15, 2025) - GuruFocus
Barclays Adjusts PT on IQVIA Holdings to $230 From $200, Maintains Equalweight Rating - marketscreener.com
Select Medical Technology and Devices Portfolio's IQVIA Holdings Inc(IQV) Holding History - GuruFocus
Why IQVIA Holdings (IQV) is a top momentum stock for the long term - MSN
Did IQVIA’s (IQV) Debt Refinancing and Lower SOFR Costs Just Shift Its Investment Narrative? - simplywall.st
IQVIA’s Strategic Moves and Strong Results Fuel Analyst Confidence - AD HOC NEWS
Lazard Asset Management LLC Acquires 107,500 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Electronic Clinical Outcome Assessment Solutions Market Projected to Reach USD 5.64 Billion by 2032 at a CAGR of 15.3% - GlobeNewswire Inc.
Bellevue Group AG Sells 27,368 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.62 Million Stock Position in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc. $IQV Shares Sold by Canada Pension Plan Investment Board - MarketBeat
CIBC Asset Management Inc Acquires 44,732 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Alliancebernstein L.P. Boosts Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
Jefferies rates IQVIA, Charles River as Buy, ICON as Hold - MSN
Why Is IQVIA (IQV) Up 6.4% Since Last Earnings Report? - MSN
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
IQVIA: Increasingly Indispensable In Drug Development (NYSE:IQV) - Seeking Alpha
State Street Corp Trims Stake in IQVIA Holdings Inc. $IQV - MarketBeat
Certara Appoints Jon Resnick as Chief Executive Officer - GlobeNewswire Inc.
Bank of Nova Scotia Increases Stock Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
Iqvia Holdings Inc Stock (IQV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.03%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):